PT783307E - Utilizacao do 2,4-diamino pirimidina 3-oxido ou de um dos seus sais no tratamento das desordens da maturacao e da estruturacao do colagenio - Google Patents

Utilizacao do 2,4-diamino pirimidina 3-oxido ou de um dos seus sais no tratamento das desordens da maturacao e da estruturacao do colagenio

Info

Publication number
PT783307E
PT783307E PT95931260T PT95931260T PT783307E PT 783307 E PT783307 E PT 783307E PT 95931260 T PT95931260 T PT 95931260T PT 95931260 T PT95931260 T PT 95931260T PT 783307 E PT783307 E PT 783307E
Authority
PT
Portugal
Prior art keywords
disorders
oxide
pct
maturation
structuration
Prior art date
Application number
PT95931260T
Other languages
English (en)
Inventor
Bruno Bernard
Jean-Baptiste Galey
Lionel Breton
Yann Mahe
Original Assignee
Oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oreal filed Critical Oreal
Publication of PT783307E publication Critical patent/PT783307E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Cosmetics (AREA)
PT95931260T 1994-09-19 1995-09-19 Utilizacao do 2,4-diamino pirimidina 3-oxido ou de um dos seus sais no tratamento das desordens da maturacao e da estruturacao do colagenio PT783307E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9411133A FR2724561B1 (fr) 1994-09-19 1994-09-19 Utilisation du 2,4-diamino pyrimidine 3-oxyde ou de l'un de ses sels dans le traitement des desordres de la maturation et de la structuration du collagene

Publications (1)

Publication Number Publication Date
PT783307E true PT783307E (pt) 2002-07-31

Family

ID=9467049

Family Applications (1)

Application Number Title Priority Date Filing Date
PT95931260T PT783307E (pt) 1994-09-19 1995-09-19 Utilizacao do 2,4-diamino pirimidina 3-oxido ou de um dos seus sais no tratamento das desordens da maturacao e da estruturacao do colagenio

Country Status (22)

Country Link
US (1) US5846552A (pt)
EP (1) EP0783307B1 (pt)
JP (1) JP2945482B2 (pt)
KR (1) KR100250939B1 (pt)
CN (1) CN1070702C (pt)
AT (1) ATE213414T1 (pt)
AU (1) AU691336B2 (pt)
BR (1) BR9508841A (pt)
CA (1) CA2199995C (pt)
CZ (1) CZ284476B6 (pt)
DE (1) DE69525539T2 (pt)
DK (1) DK0783307T3 (pt)
ES (1) ES2171550T3 (pt)
FI (1) FI971127A (pt)
FR (1) FR2724561B1 (pt)
HU (1) HU223143B1 (pt)
MX (1) MX9701996A (pt)
NO (1) NO311784B1 (pt)
PL (1) PL186385B1 (pt)
PT (1) PT783307E (pt)
RU (1) RU2153874C2 (pt)
WO (1) WO1996009048A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69831186T2 (de) * 1997-04-30 2006-06-08 Jsr Corp. Orientierungsschicht für Flüssigkristall und Verfahren zu ihrer Herstellung
US7763587B2 (en) 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
US7326717B2 (en) * 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
FR2871688B1 (fr) 2004-06-16 2008-05-16 Oreal Procede pour favoriser la penetration d'un actif et composition permettant sa mise en oeuvre
US7300649B2 (en) 2005-02-11 2007-11-27 Genepharm, Inc. Cosmetic and cosmeceutical compositions for restoration of skin barrier function
FR2902324B1 (fr) * 2006-06-20 2009-04-03 Oreal Utilisation d'acide ellagique pour le traitement de la canitie
EP1897533A1 (en) * 2006-09-08 2008-03-12 Revotar Biopharmaceuticals AG Use of 1,6-Bis [3-(3-carboxymethylphenyl)-4-(2-alpha -D-mannopyranosyl-oxy)-phenyl] hexane for the preparation of cosmetic compositions
EP1946756A1 (en) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Use of entacapone in cosmetic, dermatological and pharmaceutical compositions
WO2010013182A1 (en) 2008-07-29 2010-02-04 L'oreal Cosmetic use of microorganism(s) for the treatment of scalp disorders
FR2951938B1 (fr) 2009-10-30 2012-01-06 Oreal Utilisation d'un extrait de punica granatum pour lutter contre la canitie
CN104398418A (zh) * 2014-11-06 2015-03-11 陈爱华 一种防脱发护发素
FR3130153A1 (fr) 2021-12-15 2023-06-16 L'oreal Utilisation d’au moins un dérivé de pyrimidine 3-oxyde pour renforcer la fonction barrière de la peau

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049902A3 (en) * 1980-10-15 1982-09-01 Teijin Limited Novel thiazolo(3,2-a)pyrimidines, derivatives thereof, processes for production thereof, and pharmaceutical use thereof
FR2644460A1 (fr) * 1989-03-16 1990-09-21 Oreal Esters retinoiques de d-desosamine, leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
LU87766A1 (fr) * 1990-07-20 1992-03-11 Oreal Utilisation de derives de pyrimidine 3-oxyde pour freiner la chute des cheveux et compositions topiques mises en oeuvre
EP0548883A1 (de) * 1991-12-24 1993-06-30 Hoechst Aktiengesellschaft Substituierte Pyridin-N-oxide, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel

Also Published As

Publication number Publication date
FI971127A0 (fi) 1997-03-18
CN1070702C (zh) 2001-09-12
NO971182L (no) 1997-05-14
PL319279A1 (en) 1997-08-04
NO971182D0 (no) 1997-03-14
CZ84297A3 (en) 1997-08-13
NO311784B1 (no) 2002-01-28
KR970705998A (ko) 1997-11-03
JP2945482B2 (ja) 1999-09-06
EP0783307A1 (fr) 1997-07-16
RU2153874C2 (ru) 2000-08-10
FR2724561B1 (fr) 1996-12-13
ATE213414T1 (de) 2002-03-15
JPH10506886A (ja) 1998-07-07
CA2199995C (fr) 2002-01-15
DE69525539D1 (de) 2002-03-28
CZ284476B6 (cs) 1998-12-16
HU223143B1 (hu) 2004-03-29
CN1159755A (zh) 1997-09-17
FR2724561A1 (fr) 1996-03-22
EP0783307B1 (fr) 2002-02-20
WO1996009048A1 (fr) 1996-03-28
ES2171550T3 (es) 2002-09-16
DK0783307T3 (da) 2002-06-03
BR9508841A (pt) 1999-05-04
DE69525539T2 (de) 2002-09-26
MX9701996A (es) 1997-06-28
AU691336B2 (en) 1998-05-14
HUT76796A (en) 1997-11-28
KR100250939B1 (ko) 2000-05-01
CA2199995A1 (fr) 1996-03-28
US5846552A (en) 1998-12-08
FI971127A (fi) 1997-03-18
AU3476595A (en) 1996-04-09
PL186385B1 (pl) 2004-01-30

Similar Documents

Publication Publication Date Title
DK0850068T3 (da) Lipidekstrakt med antiinflammatorisk aktivitet
PT783307E (pt) Utilizacao do 2,4-diamino pirimidina 3-oxido ou de um dos seus sais no tratamento das desordens da maturacao e da estruturacao do colagenio
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
FR2705235B1 (fr) Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os.
HU9700056D0 (en) New pharmaceutical composition for treating pains
SE9404196D0 (sv) New antithrombotic formulation
DE69800859T2 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
FR2731907B1 (fr) Composition dermatologique et/ou cosmetique depigmentante et utilisation dans une methode cosmetique
PL338673A1 (en) Application of fanquinone in treating alzheimer disease
DE69516110T2 (de) Verwendung von riluzol zur behandlung mitochondrialer erkrankungen
HUP9902415A2 (hu) Azonnal felszabaduló szilárd beadási formák és eljárás azok előállítására
ATE268173T1 (de) Methoden zur behandlung von neurombedingten schmerzen
DE69427116T2 (de) Verwendung von 4'-iodo - 4 - deoxydoxorubicin zur behandlung von amyloidosis
EA199800953A1 (ru) Компонент в, используемый в качестве рубцующего агента, содержащая его фармацевтическая композиция и способ лечения
SE9403861D0 (sv) Novel medicinal use
DE3776662D1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
UA26407C2 (uk) Спосіб очищеhhя уражеhих шкірhих покривів людиhи при захворюваhhі псоріазом
ATE221528T1 (de) Neue 1,4-dihydropyridinderivate und deren therapeutische anwendung
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs